Key facts
- The four plaintiffs are MaryAnne Lindsey, Surenthia Jenkins, Miranda Lofton and Sandra Simpson, according to their attorney Danielle Ward Mason.
- More than 12,700 cases over the claims are centralized before a judge in federal court in Chicago, court records show.
- L'Oreal said the NIH study did not establish a causal link between the products and the conditions alleged by plaintiffs.
- Arizona and Minnesota sued L'Oreal over the products in 2026, alleging the company misled women about their safety.
- The products were marketed under names including Dark and Lovely and Optimum and widely marketed to Black women.
Four women who said chemical hair straightening products caused their cancer reached a settlement with L'Oreal's US subsidiary and other companies on November 16, during a trial in Chicago, according to their attorneys. The cases were the first of thousands over the claims to go to trial, and the settlement sum is confidential.
A spokesperson for L'Oreal said the company's highest priority is the health and wellbeing of its consumers and that it remains confident in the safety of its SoftSheen-Carson brand hair products, which include hair relaxers. "L'Oreal USA strictly follows all regulations in every market in which it operates, and its products are always subject to a rigorous scientific evaluation of their safety," the spokesperson said.
Danielle Ward Mason, an attorney for the women, MaryAnne Lindsey, Surenthia Jenkins, Miranda Lofton and Sandra Simpson, said in a statement she hoped the settlement would give the women a sense of justice. The women sued L'Oreal's US subsidiary and several other makers of the products in Cook County, Illinois, in 2023 and 2024, and the trial began on November 9 with jury selection.
More than 12,700 cases over the claims are centralized before a judge in federal court in Chicago, court records show, while some cases have been filed in state court. The products, marketed under names including Dark and Lovely and Optimum, promise to permanently straighten textured hair and have been widely marketed to Black women.
The first lawsuits followed a 2022 study by the National Institutes of Health that found women who used the products several times a year were more than twice as likely to develop uterine cancer. L'Oreal has said the study did not establish a causal link between use of the products and any conditions alleged by the plaintiffs. At least two states, Arizona and Minnesota, sued L'Oreal over the products in 2026, alleging the company had misled women about their safety.
